I agree that this site is using cookies. You can find further informations here.
X
Devadoss, Thangaraj
32  results:
Search for persons X
?
1

IDO and TGF-β Inhibitors for the Treatment of Lung Cancer:

, In: Immunotherapy Against Lung Cancer,
Devadoss, Thangaraj ; Rajendra, Yeole Kalpesh ; Rajesh, Ranmale Bhavesh. - p. 153-180 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Synthetic applications of p-toluenesulfonyl chloride: A rec..:

Devadoss, Thangaraj
Journal of Molecular Structure.  1289 (2023)  - p. 135850 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Targeting inflammation: a potential approach for the treatm..:

Bhatt, Shvetank ; Devadoss, Thangaraj ; Jha, Niraj Kumar...
Metabolic Brain Disease.  38 (2022)  1 - p. 45-59 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Synthesis of 1,6‐Naphthyridine and Its Derivatives: A Syste..:

Devadoss, Thangaraj ; Sowmya, Veldhi ; Bastati, Ravali
ChemistrySelect.  6 (2021)  15 - p. 3610-3641 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Design, synthesis and evaluation of 2-(4-(substituted benzo..:

Mahesh, Radhakrishnan ; Mundra, Sourabh ; Devadoss, Thangaraj.
Arabian Journal of Chemistry.  12 (2019)  7 - p. 1436-1446 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Construction of a novel quinoxaline as a new class of Nrf2 ..:

Kandasamy, Murugesh ; Mak, Kit-Kay ; Devadoss, Thangaraj...
BMC Chemistry.  13 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
7

Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive..:

Kurhe, Yeshwant ; Mahesh, R. ; Devadoss, Thangaraj
Psychopharmacology.  234 (2017)  7 - p. 1165-1179 , 2017
Link: https://doi.org/10.1007/..
 
?
8

QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA a..:

Kurhe, Yeshwant ; Mahesh, Radhakrishnan ; Devadoss, Thangaraj
Biochemical and Biophysical Research Communications.  456 (2015)  1 - p. 74-79 , 2015
Link: https://doi.org/10.1016/..
 
?
9

Neuropharmacological evaluation of a novel 5-HT3 receptor a..:

Bhatt, Shvetank ; Radhakrishnan, Mahesh ; Jindal, Ankur..
Indian Journal of Pharmacology.  46 (2014)  2 - p. 191 , 2014
Link: https://doi.org/10.4103/..
 
?
10

Neuropharmacological effect of novel 5-HT3 receptor antagon..:

Bhatt, Shvetank ; Mahesh, Radhakrishnan ; Jindal, Ankur.
Pharmacological Reports.  66 (2014)  5 - p. 804-810 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Protective effects of a novel 5-HT3 receptor antagonist, N-..:

Bhatt, Shvetank ; Mahesh, Radhakrishnan ; Jindal, Ankur.
Pharmacology Biochemistry and Behavior.  122 (2014)  - p. 234-239 , 2014
Link: https://doi.org/10.1016/..
 
?
12

QCM-4, a serotonergic type 3 receptor modulator attenuates ..:

Kurhe, Yeshwant ; Mahesh, Radhakrishnan ; Gupta, Deepali.
European Journal of Pharmacology.  740 (2014)  - p. 611-618 , 2014
Link: https://doi.org/10.1016/..
 
?
13

Design, Synthesis, and Pharmacological Evaluation of Novel ..:

Dhar, Arghya K. ; Mahesh, Radhakrishnan ; Jindal, Ankur..
Chemical Biology & Drug Design.  84 (2014)  6 - p. 721-731 , 2014
Link: https://doi.org/10.1111/..
 
?
14

Antidepressant-like effect of novel 5-HT3 receptor antagoni..:

Bhatt, Shvetank ; Mahesh, Radhakrishnan ; Devadoss, Thangaraj.
Indian Journal of Pharmacology.  45 (2013)  4 - p. 348 , 2013
Link: https://doi.org/10.4103/..
 
?
15

Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methox..:

Bhatt, Shvetank ; Mahesh, Radhakrishnan ; Devadoss, Thangaraj.
Indian Journal of Pharmacology.  45 (2013)  3 - p. 248 , 2013
Link: https://doi.org/10.4103/..
 
1-15